Format

Send to

Choose Destination
Mol Oncol. 2010 Dec;4(6):511-28. doi: 10.1016/j.molonc.2010.08.003. Epub 2010 Sep 8.

Targeted nanoagents for the detection of cancers.

Author information

1
Center for Systems Biology, Harvard Medical School and Massachusetts General Hospital, Boston, MA 02114, USA. jason_mccarthy@hms.harvard.edu

Abstract

Nanotechnology has enabled a renaissance in the diagnosis of cancers. This is due, in part to the ability to develop agents bearing multiple functionalities, including those utilized for targeting, imaging, and therapy, allowing for the tailoring of the properties of the nanomaterials. Whereas many nanomaterials exhibit localization to diseased tissues via intrinsic targeting, the addition of targeting ligands, such as antibodies, peptides, aptamers, and small molecules, facilitates far more sensitive cancer detection. As such, this review focuses upon some of the most poignant examples of the utility of affinity ligand targeted nanoagents in the detection of cancer.

PMID:
20851695
PMCID:
PMC2981649
DOI:
10.1016/j.molonc.2010.08.003
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center